PowerSecure Names John Bluth Senior Vice President Investor Relations and Corporate Communications

PowerSecure Names John Bluth Senior Vice President Investor Relations and Corporate Communications

PowerSecure Names John Bluth Senior Vice President Investor Relations and Corporate Communications WAKE FOREST, N.C.–(BUSINESS WIRE)–…

Continue Reading
Dollar Tree Appoints Daniel Delrosario as Senior Vice President of Investor Relations and Treasurer : Dollar Tree, Inc. (DLTR)

Dollar Tree Appoints Daniel Delrosario as Senior Vice President of Investor Relations and Treasurer : Dollar Tree, Inc. (DLTR)

Dollar Tree Appoints Daniel Delrosario as Senior Vice President of Investor Relations and Treasurer …

Continue Reading
BD Names Shawn Bevec as Senior Vice President of Investor Relations

BD Names Shawn Bevec as Senior Vice President of Investor Relations

FRANKLIN LAKES, N.J., Jan. 14, 2026 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading…

Continue Reading
Windjammer Capital Expands Senior Investment Team with the Addition of Evan Klebe and Beth Lesniak; Meredith Stein Joins as Head of Investor Relations

Windjammer Capital Expands Senior Investment Team with the Addition of Evan Klebe and Beth Lesniak; Meredith Stein Joins as Head of Investor Relations

Windjammer Capital (“Windjammer”), a national private equity investment firm focused on control equity investments in middle-market…

Continue Reading
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets

Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets

BOSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing…

Continue Reading
Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets

Pyxis Oncology Appoints Alex Kane as Senior Vice President, Investor Relations & Capital Markets

Pyxis Oncology BOSTON, Oct. 09, 2025 (GLOBE NEWSWIRE) — Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage…

Continue Reading